Become A Featured Company

PreveCeutical Medical Inc. Engages CFN Media to Cultivate New Investor Audience

Ryan Allway

April 13th, 2017

News, Top News

CFN Media Group (“CFN Media”, CannabisFN”), the leading agency and digital media network dedicated to the North American cannabis industry, today announced that PreveCeutical Medical Inc. (“PreveCeutical”) has engaged CFN Media to conduct a 5-month investor and market visibility program beginning on April 13, 2017.

“We are excited to be working with PreveCeutical Medical; a pre-public company that plans on going public in early summer,” said Frank Lane, President of CFN Media. “The company’s innovative approach to developing prevention-focused therapies will transform the pharmaceutical mode. It’s nutraceutical product CELLB9 has the potential to enhance the lives of millions of individuals while its cannabis based research represents promising life-saving potential ahead.”

PreveCeutical is holding a corporate presentation at the Fairmont Waterfront Hotel, Malaspina Room at 900 Canada Place in Vancouver, BC on Thursday, April 27, 2017 from 1:30pm to 6:00pm (Pacific Standard Time), which investors can register for free via EventBrite: https://www.eventbrite.ca/e/preveceutical-medical-inc-corporate-presentation-tickets-33258076803?aff=ehomecard

“Working with CFN Media will allow PreveCeutical to reach market demographics that will be interested in our product offering and growth potential. We look forward to working with CFN Media,” said Stephen Van Deventer, PreveCeutical’s Chief Executive Officer and Chairman of the Board.

CFN Media will leverage its extensive reach and presence with mainstream and cannabis-focused investors and media across North America to elevate PreveCeutical’s brand and attract high-quality long-term investors.

Learn how to become a CFN Media client company, brand or entrepreneur: https://cannabisfn.com/become-featured-company/

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: https://cannabisfn.com

About CFN Media

CFN Media (CannabisFN), the leading creative agency and media network dedicated to the worldwide cannabis industry, helps marijuana businesses attract investors, customers (B2B, B2C), capital, and publicity. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

The company launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.

About PreveCeutical Medical Inc.

PreveCeutical is a bio pharmaceutical company with headquarters in Vancouver, British Columbia, Canada.  The Company is focused on utilizing nature and science for the benefit of health-conscious consumers and currently has one product available for sale, the CELLB9 TM immune-system booster. CELLB9 TM is an oral solution containing essential minerals extracted from a novel peptide obtained from the venom of the Caribbean Blue Scorpion. The active potentiated ingredients in the Blue Scorpion serum appear to support health at a deep cellular level, having been used for many years and in over 40 countries.

PreveCeutical is led by an experienced team of senior executives and scientists who believe that the western world is now in transition from a system which “fixes people after they are sick” to one of precision health based on preventative, diagnostic genomic-based medicine. With this focus, the Company is committed to become a leader in the fast-emerging preventive health sector.

More information is available online at http://www.preveceutical.com

Cautionary Language and Forward Looking Statements:

This news release does not constitute an offer to sell or a solicitation of an offer to buy the securities of PreveCeutical in the United States, or in any jurisdiction in which such an offer or sale would be unlawful. No securities of PreveCeutical have been and will be registered under the United States Securities Act of 1933, as amended (the “1933 Act”) or any United States state securities laws, and they may not be offered or sold in the United States or to the account or benefit of a “U.S. person” (as defined in Regulation S under the 1933 Act) or a person in the United States absent registration or an applicable exemption from the registration requirements.

This news release includes certain statements that constitute “forward-looking information” within the meaning of applicable laws. Readers are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly, are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements. Statements in this news release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations and orientations regarding the future. Often, but not always, forward-looking statements can be identified by words such as “pro forma”, “plans”, “expects”, “may”, “should”, “budget”, “schedules”, estimates”, “forecasts”, “intends”, “anticipates”, “believes”, “potential” or variations of such words including negative variations thereof and phrases that refer to certain actions, events or results that may, could, would, might or will occur or be taken or achieved. Such forward-looking statements include, among others, statements as to the anticipated business plans of PreveCeutical, its future business prospects, and it planned going public strategy. Actual results could differ from those projected in any forward-looking statements due to numerous factors including adverse market conditions, risks regarding protection of proprietary technology, the ability of PreveCeutical to develop and market its future products, risks regarding government regulation, risks and uncertainties relating to the inability of PreveCeutical to successfully implement its business plan. Any public listing or going public transaction is subject to regulatory and shareholder approval. These forward-looking statements are made as of the date of this news release and, unless required by applicable law, no party mentioned in this news release assumes an obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in these forward-looking statements. Although CFN Media and PreveCeutical believe that the beliefs, plans, expectations and intentions contained in this news release are reasonable, there can be no assurance that those beliefs, plans, expectations or intentions will prove to be accurate. Readers should consider all of the information set forth herein and should also refer to other periodic news releases issued by CFN Media and PreveCeutical.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading